Latest filing published 20 Dec 2012 for DUSA PHARMACEUTICALS INC, €324k.
No signal scores available.
This profile gathers the share dealings of William F. ODell in Dusa Pharmaceuticals Inc. In total, 17 filings cover trades dated from 9 May 2008 to 20 December 2012.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 20 December 2012 came the latest disclosure, a transaction for €324k in Dusa Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations